ClinVar Miner

Submissions for variant NM_004998.4(MYO1E):c.2050-3C>T

gnomAD frequency: 0.00001  dbSNP: rs776916643
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001364296 SCV001560436 uncertain significance not provided 2021-09-26 criteria provided, single submitter clinical testing This sequence change falls in intron 19 of the MYO1E gene. It does not directly change the encoded amino acid sequence of the MYO1E protein. It affects a nucleotide within the consensus splice site of the intron. This variant is present in population databases (rs776916643, ExAC 0.1%). This variant has not been reported in the literature in individuals affected with MYO1E-related conditions. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV002488122 SCV002794289 uncertain significance Focal segmental glomerulosclerosis 6 2022-03-31 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.